Correction: An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System

Affiliations

• ¹ Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD, USA. Scott.Janiczak@fda.hhs.gov.
• ² Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD, USA.
• ³ Office of Strategic Partnerships and Technology Innovation, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
• ⁴ Office of Biostatistics, US Food and Drug Administration, Silver Spring, MD, USA.